How many institutions held MYNZ - MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value in Q4 2022?

6 institutional investors reported MYNZ - MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value for Q4 2022. Use the holders table for investor-level position and value details.

MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (MYNZ)

Q: What does CUSIP N5436L101 represent in this 13F holders report?

CUSIP N5436L101 is the security identifier for MYNZ - MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value used to aggregate holder disclosures.

CUSIP: N5436L101

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Ordinary Shares, (euro)0.01 nominal value
Shares outstanding: 489,733,060
Total 13F shares: 20,102
Share change: +3,468
Total reported value: $135,392
Price per share: $7.10
Number of holders: 6
Value change: +$24,313
Number of buys: 3
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP N5436L101?
CUSIP N5436L101 identifies MYNZ - MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP N5436L101:

Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023

Top shareholders of MYNZ - MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Greenwich Investment Management, Inc.	13F	Company	0%	14,724	$101,000	—	30 Sep 2022	13F
CITIGROUP INC	13F	Company	0%	673	$5,000	—	30 Sep 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	149	$1,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	0%	88	$1,000	—	30 Sep 2022	13F

Institutional Holders of MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (MYNZ) as of Q4 2022

As of 31 Dec 2022, MAINZ BIOMED N.V. - Ordinary Shares, (euro)0.01 nominal value (MYNZ) was held by 6 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 20,102 shares. The largest 6 holders included Greenwich Investment Management, Inc., UBS Group AG, Steward Partners Investment Advisory, LLC, NewEdge Advisors, LLC, CITIGROUP INC, and WELLS FARGO & COMPANY/MN. This page lists 6 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.